Loading clinical trials...
Loading clinical trials...
A Multi-Center Oral Contraceptive Pill Use Trial Conducted In an OTC Naturalistic Environment (OPTION)
Conditions
Interventions
Norgestrel 0.075 mg tablets
Locations
44
United States
HRA Pharma Investigational site
Birmingham, Alabama, United States
HRA Pharma Investigational site
Homewood, Alabama, United States
HRA Pharma Investigational site
McCalla, Alabama, United States
HRA Pharma Investigational site
Tucson, Arizona, United States
HRA Pharma Investigational site
Downey, California, United States
HRA Pharma Investigational site
La Habra, California, United States
Start Date
April 27, 2018
Primary Completion Date
September 9, 2018
Completion Date
November 14, 2018
Last Updated
April 4, 2022
NCT06345586
NCT07115849
NCT06672016
NCT07365904
NCT07320651
NCT06334315
Lead Sponsor
HRA Pharma
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions